Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Leese

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
NEJM Evidence|June 21, 2024
Effect of Fenofibrate on Progression of Diabetic RetinopathyDavid Preiss, Jennifer Logue, Emily Sammons, et al.
Journal of Diabetes Science and Technology|July 5, 2011
Using web technology to support population-based diabetes careScott Cunningham, Ritchie McAlpine, Graham Leese, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 5, 2009
Blunting of AICAR-induced human skeletal muscle glucose uptake in type 2 diabetes is dependent on age rather than diabetic statusJohn Andree Babraj, Kristy Mustard, Calum Sutherland, et al.
Diabetologia|February 12, 2015
Ethnicity and risk of cardiovascular disease (CVD): 4.8 year follow-up of patients with type 2 diabetes living in ScotlandMuhammad Omar Malik, L Govan, John R Petrie, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 3, 2025
Cost-effectiveness of fenofibrate versus standard care for reducing the progression of diabetic retinopathy: An economic evaluation based on data from the LENS trialGraham Scotland, Mekazin Tsehaye, Caroline Styles, et al.
Diabetes|April 2, 2009
Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS studyKaixin Zhou, Louise A Donnelly, Charlotte H Kimber, et al.
Health Technology Assessment (Winchester, England)|May 12, 2026
Fenofibrate and progression of retinopathy in adults with diabetes: the randomised placebo-controlled LENS trialDavid Preiss, Jennifer Logue, Emily Sammons, et al.
Health Technology Assessment (Winchester, England)|November 25, 2020
Risk assessments and structured care interventions for prevention of foot ulceration in diabetes: development and validation of a prognostic modelFay Crawford, Francesca M Chappell, James Lewsey, et al.
The British Journal of Ophthalmology|April 1, 2014
Improving the cost-effectiveness of photographic screening for diabetic macular oedema: a prospective, multi-centre, UK studyGordon Prescott, Peter Sharp, Keith Goatman, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|April 5, 2018
Multicenter, randomized controlled, observer-blinded study of a nitric oxide generating treatment in foot ulcers of patients with diabetes-ProNOx1 studyMichael E Edmonds, Harvey J Bodansky, Andrew J M Boulton, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
NEJM Evidence|June 21, 2024
Effect of Fenofibrate on Progression of Diabetic RetinopathyDavid Preiss, Jennifer Logue, Emily Sammons, et al.
Journal of Diabetes Science and Technology|July 5, 2011
Using web technology to support population-based diabetes careScott Cunningham, Ritchie McAlpine, Graham Leese, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 5, 2009
Blunting of AICAR-induced human skeletal muscle glucose uptake in type 2 diabetes is dependent on age rather than diabetic statusJohn Andree Babraj, Kristy Mustard, Calum Sutherland, et al.
Diabetologia|February 12, 2015
Ethnicity and risk of cardiovascular disease (CVD): 4.8 year follow-up of patients with type 2 diabetes living in ScotlandMuhammad Omar Malik, L Govan, John R Petrie, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 3, 2025
Cost-effectiveness of fenofibrate versus standard care for reducing the progression of diabetic retinopathy: An economic evaluation based on data from the LENS trialGraham Scotland, Mekazin Tsehaye, Caroline Styles, et al.
Diabetes|April 2, 2009
Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS studyKaixin Zhou, Louise A Donnelly, Charlotte H Kimber, et al.
Health Technology Assessment (Winchester, England)|May 12, 2026
Fenofibrate and progression of retinopathy in adults with diabetes: the randomised placebo-controlled LENS trialDavid Preiss, Jennifer Logue, Emily Sammons, et al.
Health Technology Assessment (Winchester, England)|November 25, 2020
Risk assessments and structured care interventions for prevention of foot ulceration in diabetes: development and validation of a prognostic modelFay Crawford, Francesca M Chappell, James Lewsey, et al.
The British Journal of Ophthalmology|April 1, 2014
Improving the cost-effectiveness of photographic screening for diabetic macular oedema: a prospective, multi-centre, UK studyGordon Prescott, Peter Sharp, Keith Goatman, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|April 5, 2018
Multicenter, randomized controlled, observer-blinded study of a nitric oxide generating treatment in foot ulcers of patients with diabetes-ProNOx1 studyMichael E Edmonds, Harvey J Bodansky, Andrew J M Boulton, et al.
Pageof 4